206 related articles for article (PubMed ID: 12767525)
1. Prognostic potential of glutathione S-transferase M1 and T1 null genotypes for gastric cancer progression.
Choi SC; Yun KJ; Kim TH; Kim HJ; Park SG; Oh GJ; Chae SC; Oh GJ; Nah YH; Kim JJ; Chung HT
Cancer Lett; 2003 Jun; 195(2):169-75. PubMed ID: 12767525
[TBL] [Abstract][Full Text] [Related]
2. Is there any association of glutathione S-transferase T1 (GSTT1) and glutathione S-transferase M1 (GSTM1) gene polymorphism with gastric cancers?
Haholu A; Berber U; Karagöz B; Tuncel T; Bilgi O; Demirel D
Pol J Pathol; 2013 Dec; 64(4):247-52. PubMed ID: 24375038
[TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma.
Katoh T; Nagata N; Kuroda Y; Itoh H; Kawahara A; Kuroki N; Ookuma R; Bell DA
Carcinogenesis; 1996 Sep; 17(9):1855-9. PubMed ID: 8824506
[TBL] [Abstract][Full Text] [Related]
4. Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers.
Saadat I; Saadat M
Cancer Lett; 2001 Aug; 169(1):21-6. PubMed ID: 11410321
[TBL] [Abstract][Full Text] [Related]
5. GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case-control study in a Chinese population.
Setiawan VW; Zhang ZF; Yu GP; Li YL; Lu ML; Tsai CJ; Cordova D; Wang MR; Guo CH; Yu SZ; Kurtz RC
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):73-80. PubMed ID: 10667466
[TBL] [Abstract][Full Text] [Related]
6. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
7. Glutathione-S-transferase (GSTM1, GSTT1) null phenotypes and risk of lung cancer in a Korean population.
Piao JM; Shin MH; Kim HN; Cui LH; Song HR; Kweon SS; Choi JS; Kim YC; Oh IJ; Kim KS
Asian Pac J Cancer Prev; 2013; 14(12):7165-9. PubMed ID: 24460270
[TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans.
Martínez C; Martín F; Fernández JM; García-Martín E; Sastre J; Díaz-Rubio M; Agúndez JA; Ladero JM
Pharmacogenomics; 2006 Jul; 7(5):711-8. PubMed ID: 16886896
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between GSTM1, GSTT1 gene polymorphisms and susceptibility to sporadic colorectal adenocarcinoma].
Zhu Y; Deng C; Zhang Y; Zhou X; He X
Zhonghua Nei Ke Za Zhi; 2002 Aug; 41(8):538-40. PubMed ID: 12421502
[TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran.
Safarinejad MR; Shafiei N; Safarinejad SH
Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):105-13. PubMed ID: 21243008
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
[TBL] [Abstract][Full Text] [Related]
12. Association between glutathione S-transferase M1 and T1 polymorphisms and increased risk for bladder cancer in Korean smokers.
Jong Jeong H; Jin Kim H; Young Seo I; Ju Kim H; Oh GJ; Cheon Chae S; Sik Lim J; Taeg Chung H; Joong Kim J
Cancer Lett; 2003 Dec; 202(2):193-9. PubMed ID: 14643449
[TBL] [Abstract][Full Text] [Related]
13. Glutathione-S-transferase P1, T1 and M1 genetic polymorphisms in neoadjuvant-treated locally advanced gastric cancer: GSTM1-present genotype is associated with better prognosis in completely resected patients.
Ott K; Lordick F; Becker K; Ulm K; Siewert J; Höfler H; Keller G
Int J Colorectal Dis; 2008 Aug; 23(8):773-82. PubMed ID: 18443805
[TBL] [Abstract][Full Text] [Related]
14. Molecular evaluation of glutathione S transferase family genes in patients with sporadic colorectal cancer.
Rodrigues-Fleming GH; Fernandes GMM; Russo A; Biselli-Chicote PM; Netinho JG; Pavarino ÉC; Goloni-Bertollo EM
World J Gastroenterol; 2018 Oct; 24(39):4462-4471. PubMed ID: 30356976
[TBL] [Abstract][Full Text] [Related]
15. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma.
Kim JW; Lee CG; Park YG; Kim KS; Kim IK; Sohn YW; Min HK; Lee JM; Namkoong SE
Cancer; 2000 May; 88(9):2082-91. PubMed ID: 10813720
[TBL] [Abstract][Full Text] [Related]
16. CYP1A1 (Ile462Val), CYP1B1 (Ala119Ser and Val432Leu), GSTM1 (null), and GSTT1 (null) polymorphisms and bladder cancer risk in a Turkish population.
Berber U; Yilmaz I; Yilmaz O; Haholu A; Kucukodaci Z; Ates F; Demirel D
Asian Pac J Cancer Prev; 2013; 14(6):3925-9. PubMed ID: 23886208
[TBL] [Abstract][Full Text] [Related]
17. Glutathione S-transferase M1, T1 and P1 genetic polymorphisms, cigarette smoking and gastric cancer risk.
Tamer L; Ateş NA; Ateş C; Ercan B; Elipek T; Yildirim H; Camdeviren H; Atik U; Aydin S
Cell Biochem Funct; 2005; 23(4):267-72. PubMed ID: 15473001
[TBL] [Abstract][Full Text] [Related]
18. Glutathione S-transferase M1 and T1 polymorphisms and cervical cancer risk: a meta-analysis.
Wang D; Wang B; Zhai JX; Liu DW; Sun GG
Neoplasma; 2011; 58(4):352-9. PubMed ID: 21520994
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility and outcomes in muscle invasive bladder cancer patients.
Kang HW; Song PH; Ha YS; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YH; Moon SK; Kim WJ
Eur J Cancer; 2013 Sep; 49(14):3010-9. PubMed ID: 23810248
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the Glutathione-S-Transferase P1, M1, and T1 Genotypes and Prostate Cancer Risk in Korean Subjects.
Kwon DD; Lee JW; Han DY; Seo IY; Park SC; Jeong HJ; Yang YS; Chae SC; Na KS; Mo KJ; Kim JJ; Rim JS
Korean J Urol; 2011 Apr; 52(4):247-52. PubMed ID: 21556210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
